Clinical trial of MW drug on critical patients gave good results: CSIR Director General

Shekhar C. Mande, Director Genral of Council for Scientific and Industrial Research while talking to ABP News about the trial of MW drug against the novel COVID-19 said that the CSIR has received permission for the third stage of the trial.

When the MW drug was clinically tried on the critical patents, it showed good results after which the permission for third stage trial was granted.